MDNC.US Medinotec Inc.
- Market cap
- USD 58.8M
- P/E
- 27.8x
- P/B
- 13.74x
- ROE
- 8.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Aug 2026.
Is MDNC.US undervalued?
Graham numberThe Graham number of Medinotec Inc. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medinotec Inc. fundamental analysis
No fundamental analysis for Medinotec Inc. yet.
Medinotec Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medinotec Inc.
Medinotec Inc. engages in the research and development, production, and sale of medical devices used in cardiology and airway-related procedures in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents; and distributes a range of cardiology and renal dia…
Full company profileMedinotec Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Medinotec Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 1,000K | 5.02M | 9.11M | 9.73M | 11.7M |
| Gross Profit | - | 582K | 2.44M | 4.82M | 5.13M | 5.74M |
| Operating Income | - | -239K | -41.4K | 3.19M | 1.09M | 767K |
| EBITDA | - | -111K | 112K | 3.27M | 1.24M | 895K |
| Net Income | - | -353K | -405K | 2.16M | 795K | 526K |
| EPS | - | -0.03 | -0.03 | 0.18 | 0.07 | 0.04 |
| Balance Sheet | ||||||
| Total Assets | 1.32M | 4.49M | 4.80M | 6.81M | 6.81M | 6.95M |
| Total Liabilities | 1.79M | 1.93M | 2.64M | 2.54M | 1.10M | 1.02M |
| Shareholders' Equity | -470K | 2.56M | 2.17M | 4.27M | 5.71M | 5.93M |
| Cash & Short-term Investments | 132K | 2.83M | 2.81M | 2.77M | 2.76M | 2.58M |
| Cash Flow | ||||||
| Operating Cash Flow | -732.00 | -491K | 14.2K | 878K | 907K | -137K |
| Capital Expenditure | 0.00 | 0.00 | 2.26K | 89.0K | 1.36K | 174K |
| Free Cash Flow | - | -491K | 12.0K | 789K | 905K | -311K |
| Ratios | ||||||
| ROE | - | -13.8% | -18.7% | 50.6% | 13.9% | 8.9% |
| ROA | - | -7.9% | -8.4% | 31.7% | 11.7% | 7.6% |
| Net Profit Margin | - | -35.3% | -8.1% | 23.7% | 8.2% | 4.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Medinotec Inc. dividends
Medinotec Inc. has not paid dividends in the last 5 fiscal years.
Who owns Medinotec Inc.
- Insiders 84.43%
- Institutions 0.00%
- Public & others 15.57%
- Shares outstanding 11.8M
- Free float 1.81M
Medinotec Inc. company profile
- Company name
- Medinotec Inc.
- Ticker
- MDNC.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 36
- Fiscal year end
- February
- Address
- Northlands Deco Park, Johannesburg, South Africa, 2169
- Phone
- 27 87 330 2301
- Website
- medinotecinc.com
About Medinotec Inc.
Medinotec Inc. engages in the research and development, production, and sale of medical devices used in cardiology and airway-related procedures in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents; and distributes a range of cardiology and renal dialysis products. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.
Medinotec Inc. management
2- Dr. Gregory VizirgianakisPresident, Chairman, Secretary, CEO & Director · born 1979
- Mr. Pieter van NiekerkChief Operating Officer, CFO, Treasurer & Director · born 1985